期刊文献+

羟乙基淀粉130/0.4电解质注射液等容血液稀释对老年患者肝肿瘤切除术中凝血功能的影响 被引量:6

Effects of normovolemic hemodilution with hetastarch starch 130/0.4 and electrolyte solution on blood coagulation during resection for liver cancer in elderly patients
原文传递
导出
摘要 目的 评价羟乙基淀粉130/0.4电解质注射液等容血液稀释对老年患者肝肿瘤切除术中凝血功能的影响.方法 拟在全麻下行择期肝肿瘤切除术老年患者40例,ASA分级Ⅱ级,年龄65 ~ 74岁,按照随机数字表法分为2组(n=20):对照组(C组)和等容血液稀释组(NH组).NH组在麻醉诱导后静脉输注6%羟乙基淀粉130/0.4电解质注射液行等容血液稀释,C组行常规容量管理.于麻醉诱导前(T1)、等容血液稀释后30 min(T2)、手术1 h(T3)和术毕(T4)时采集静脉血样,测定凝血功能常规指标、可溶性纤维蛋白单体复合物(SFMC)及血小板膜糖蛋白(PAC-1)的水平.结果 与C组比较,NH组术中出血量、凝血酶原时间、活化部分凝血活酶时间、SFMC及PAC-1的水平差异无统计学意义(P>0.05),术中异体输血量减少,T2-4时纤维蛋白原浓度下降(P<0.05);与T1比较,T2-4时NH组纤维蛋白原浓度下降,2组凝血酶原时间和活化部分凝血活酶时间延长(P<0.05),但仍在正常范围,而其他指标差异无统计学意义(P>0.05).结论 羟乙基淀粉130/0.4电解质注射液等容血液稀释对老年患者肝肿瘤切除术中凝血功能无明显影响,且具有一定的血液保护作用. Objective To evaluate the effects of normovolemic hemodilution (NH) with hetastarch starch 130/0.4 and electrolyte solution on blood coagulation during resection for liver cancer in the elderly patients.Methods Forty patients,of ASA physical status Ⅱ,aged 65-74 yr,scheduled for elective resection for liver cancer under general anesthesia,were randomly divided into NH group (n =20) and control group (group C,n =20).NH group underwent NH with 6% hematocrit starch 130/0.4 and electrolyte solution after induction of anesthesia,while group C underwent routine fluid management.Before induction of anesthesia (T1),at 30 min after NH (T2),at 1 h during operation (T3),and at the end of operation (T4),venous blood samples were collected for measurement of the routine parameters of blood coagulation,and levels of soluble fibrin monomer complex (SFMC),and platelet membrane glycoprotein (PAC-1,platelet activation marker).Results Compared with group C,no significant changes were found in intraoperative blood loss,PT,APTT,and levels of SFMC and PAC-1,the volume of allogeneic blood transfused was reduced,and Fib was decreased at T2-4 in NH group.Compared with the baseline value at T1,Fib was decreased significantly at T2-4 in NH group,and PT and APTT were prolonged but still within the normal range,and no significant changes were found in the other parameters in both groups.Conclusion NH with hetastarch starch 130/0.4 and electrolyte solution exerts no effect on blood coagulation during resection for liver cancer and provides blood-saving effect to some extent in the elderly patients.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2014年第7期839-842,共4页 Chinese Journal of Anesthesiology
关键词 老年人 肝切除术 羟乙基淀粉 血液稀释 血液凝固试验 Aged Hepatectomy Hetastarch Hemodilution Blood coagulation tests
  • 相关文献

参考文献8

  • 1Martin G , Bennett-Guerrero E, Wakeling H, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery[J]. J Cardiothorac Vasc Anesth, 2002,16(4): 441-446.
  • 2Roche AM, James MF, Bennett-Guerrero E, et al. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystatloid and colloid intravenous fluids [ J ].Anesth Analg, 2006,102(4) : 1274-1279.
  • 3Ahn H J, Yang M, Gwak MS, et al. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-baed low molecular weight hydroxyethyl starch solutions during the atthepatic period of liver transplantation [ J ]. Anaesthesia, 2008,63 (3) : 235-242.
  • 4周欣,张晓乐.羟乙基淀粉扩容液临床研究进展[J].中国药学杂志,2007,42(9):646-649. 被引量:23
  • 5梁桦,杨承祥,曾因明,李恒,王汉兵.不同胶体溶液急性高容血液稀释对结肠癌根治术患者围术期GPⅡb/Ⅲa、P-选择素表达的影响[J].中华麻醉学杂志,2006,26(10):898-900. 被引量:6
  • 6Harrier G, Sehinzel H, Ehrenthal W, et al. Influence of hlood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thromhin-antithrombin m complex [ J ]. Ann Hematol, 1993,67 ( 3 ) : 121-125.
  • 7Pelzer H,Schwarz A, StOher W.Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide[J]. Thmmb Haemost, 1991,65(2) : 153-159.
  • 8Michelson AD, Barnard MR, Krueger LA, et al. Evaluation of platelet function by flow cytometry [ J ]. Methods, 2000,21 ( 3 ) : 259-270.

二级参考文献29

  • 1吴肇汉.外科病人液体治疗的现代概念[J].外科理论与实践,2004,9(4):343-344. 被引量:15
  • 2BARON J F.Crystalloids versus colloids in the treatment of hypovolemic shock[ A ].In:Vincent J L,ed.Yearbook of Intensive Care and Emergency Medicine[ M ].Berlin:Springer,2000:443-466.
  • 3TREIB J,HAASS A,PINDUR G,et al.All medium starches are not the same:influence of the de-gree of hydroxyethyl subst:tution of hydroryethyl starch on plasma volume,hemorrheolog-ic conditions,and coagulation[ J ].Transfu,1996,36 (5):450-455.
  • 4TREIB J,HAASS A,PINDUR G,et al.Influence of the C2/C6 hydroxyethylation ratio of hydro-xyethyl starch (HES) on hemorheology,coagulation and elimination kinetics[ J ].Thromb Haemost,1995,74(6):1452-1456.
  • 5LAXENAIRE M C,CHARPENTIER C,FELDMAN L.Anaphylactoid reactions to colloid plasma substitutes:Incidence,risk factors mechanisms.A French multicenter prospective study[ J].Ann Fr Anesth Reanim,1994,13(3):301-310.
  • 6BOLDT J,LEHMANN A,ROMPERT R,et al.Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardio pulmonary bypass[ J ].J Cardiothorac Vasc A nesth,2000,14(3):264-268.
  • 7DEHNE M G,MUHLING J,SABLOTZKI A,et al.Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment[J].J Clin Anesth,2001,13(2):103-111.
  • 8YEH T J,PARMAR J M,REBEYKA I M,et al.Limiting edema in neonatal cardio pulmonary by pass with narrow range molecular weight hydroxyethyl starch[ J ].J Thorac Cardiovasc Surg,1992,104(3):659-665.
  • 9WISSELINK W,PATETSIOS P,PANETTA T F,et al.Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in ananimal model of spinal cord ischemia[J].J Vasc Surg,1998,27(1):109-116.
  • 10CHIANG C H,WU C P,PERNG W C,et al.Dexamethasone and pentastarch produce additive attenuation of ischaemia/reperfusion lung injury[J].Clin Sci,2000,99(5):413-419.

共引文献27

同被引文献57

  • 1管向东.失血性休克[J].中国实用外科杂志,2006,26(12):916-919. 被引量:13
  • 2周欣,张晓乐.羟乙基淀粉扩容液临床研究进展[J].中国药学杂志,2007,42(9):646-649. 被引量:23
  • 3黄几平.人工胶体的分类及临床应用进展[J].国际生物医学工程杂志,2007,30(5):319-322. 被引量:4
  • 4Roche AM, James MF, Bennett-Guerrero E, et al. A head- to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids[J]. Anesth Analg,2006,102 (4) : 1274- 1279.
  • 5Ahn HJ, Yang M, Gwak MS,et al. Coagulation and bio- chemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver trans- plantation[J]. Anaesthesia, 2008,63 (3) : 235-242.
  • 6Cho JE, Shim JK, Song JW, et al. Effect of 6% hydroxyetnyl starch 130/0.4 as a priming solution on coagulation and inflammation following complex heart gurgery[J].Yonsei Med J,2014;55(3):625-634.
  • 7Akay MO, Bilir A, Oge T, et al. The evaluation of hydroxyethyl starch(6% HES 130/0.4) solution's potential preventive effects on coagulation status in women with gynecologic malignancies using rotation thromboelastography[J].Turk J Haematol,2014;31 (3) :261-265.
  • 8Viljoen A, Page PC, Fosgate GT haemodilutional effects of a et al. Coagulation, oncotic and third generation hydroxyethyl starch(130/0.4) solution in horses[J].Equine Vet J 2014;46(6):739-744.
  • 9Skhirtladze K, Base EM, Lassnigg A, et al. Comparison of the effects of albumin 5%,hydroxyethyl starch 130/0.4 6%,and Ringer's lactate on blood loss and coagulation after cardiac surgery[J].Br J Anaesth, 2014;112(2):255-264.
  • 10Cho JE, Shim JK, Song JW, et al. Effect of 6% hydroxy-ethyl starch 130/0.4 as a priming solution on coagulation and inflammation following complex heart surgery [J]. Yonsei Med J,2014,55(3):625-634.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部